It currently sells a powerful opiate.
Here’s your daily round-up of pot-news, excerpted from the newsletter WeedWeek.
The Intercept reports that Insys Therapeutics, the company that donated $500,000 to oppose REC in Arizona, is about to release a synthetic THC spray to relieve side effects associated with chemotherapy that would compete directly with MED. It’s been more widely noted that Insys’ only current product is an opioid spray. Insys noted in a 2007 SEC filing that legalization is a threat to its business.
Forbes surveys a list of cannabis-involved pharmaceutical companies that are takeover targets. Insys is among them.